CareDx (NASDAQ:CDNA – Get Free Report) had its price objective lifted by equities researchers at BTIG Research from $45.00 to $60.00 in a research report issued to clients and investors on Thursday,Benzinga reports. HC Wainwright restated a “neutral” rating and set a $46.00 price objective on shares of CareDx in a research report on Friday, July 31st. Get CareDx alerts:Get Our Latest Research Report on CDNACareDx Price PerformanceCDNA stock opened at $45.50 on Thursday. Over the last three months, insiders sold 78,936 shares of company stock valued at $2,093,708. Globeflex Capital L P now owns 119,252 shares of the company’s stock worth $2,070,000 after buying an additional 39,457 shares during the period.